11:34 AM EST - SXC Health Solutions Corp. : and Catalyst Health Solutions, Inc. today announced that their Boards of Directors have unanimously approved a definitive merger agreement under which SXC and Catalyst will combine in a cash and stock transaction valued at approximately $4.4 billion. Under the terms of the agreement, Catalyst shareholders will receive $28.00 in cash and 0.6606 shares of SXC stock for each Catalyst share, which implies a purchase price of $81.02 per Catalyst share and a premium of approximately 28% based on the closing stock prices of SXC and Catalyst on April 17. SXC Health Solutions Corp.
shares T.SXC are trading up $6.32 at $85.95.
